Why the study?
Do low molecular weight heparins prevent post-operative deep vein thrombosis as effectively as standard heparin in post-operative patients?
Do low molecular weight heparins prevent post-operative deep vein thrombosis as effectively as standard heparin in post-operative patients?
Answers are grounded in this paper and cite their sources.
While low molecular weight heparins offer the convenience of once-daily dosing for DVT prophylaxis, unresolved issues with standardization and dosing currently limit their clinical application and safety compared to standard heparin.
Preliminary clinical trials suggest that at least some low molecular weight (LMW) heparins are as effective as heparin in preventing post-operative deep vein thrombosis, and need only be injected once a day. However, a firm basis does not exist for assigning potency estimates to different LMW heparins. Caution is therefore necessary in determining appropriate dosages for various clinical indications. Until the problems of standardization and dosage are resolved, LMW heparins are unlikely to achieve their potential usefulness, or prove safer than standard heparin.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: